Date: 2014-06-12
Type of information: Capital increase
Company: Integragen (France)
Investors:
Amount: €4.6 million
Funding type: capital increase
Planned used: The funds raised will be used to support the final development and commercialisation stages of Integragen\'s diagnostic products and clinical genomics products in oncology and autism.
Others: * On June 12, 2014, IntegraGen, a French player in genomic services and the development of molecular diagnostic tests in autism and oncology,has successfully completed its capital increase launched on the market on June 3. The total number of issued shares without preferential subscription rights, was 851 851.The subscription price was set at € 5.4 per share. The company has raised € 4.6 million, including the issue premium.The offering was oversubscribed almost two times.
Therapeutic area: Cancer - Oncology - CNS diseases
